Tsumura & Co. (4540) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tsumura & Co. (4540:JPX), powered by AI.

Current Price
¥3,723
P/E Ratio
8.7
Market Cap
282.6B
Sector
Healthcare
What is the Tsumura & Co. stock price forecast?

Tsumura & Co. is currently trading at ¥3,723. View real-time AI analysis on Alpha Lenz.

What is Tsumura & Co. insider trading activity?

View the latest insider trading data for Tsumura & Co. on Alpha Lenz.

What is Tsumura & Co.'s P/E ratio?

Tsumura & Co.'s P/E ratio is 8.7.

Tsumura & Co.

JPX · 4540
¥3,723-1(-0.03%)Market closedJPX regular session 09:00–15:00 JST
Ask about Tsumura & Co.'s future dividend policy...
Alpha Chat Insight

Tsumura & Co. trades at a P/E of 8.7 (undervalued) with solid ROE of 11.4%. 3Y revenue CAGR of 11.8% highlights clear growth momentum.

Ask for details

Company Overview

Tsumura & Co. is a prominent player in the pharmaceutical industry, chiefly engaged in the manufacture and distribution of Kampo medicines, which are traditional Japanese herbal remedies. These products are developed in-house, drawing on centuries-old practices to address a wide range of health conditions through natural ingredients. Tsumura & Co. plays a vital role in integrating traditional medicine with contemporary healthcare needs, offering an alternative or complement to conventional drug therapies. The company is deeply involved in research and development, ensuring the efficacy and safety of its offerings while expanding its applications across various health sectors. Located in Japan, Tsumura & Co. is pivotal in how traditional Asian medicinal practices are appreciated and integrated into the modern pharmaceutical landscape. Their contributions are significant not only to healthcare practitioners and patients seeking alternative therapies but also in maintaining the cultural heritage and scientific validation of Kampo medicine in global markets.

CEOMr. Terukazu Kato
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees4,272

Company Statistics

FY 2025

Profile

¥282,639,456,375Market Cap
¥181,093,000,000Revenue
0.00Shares Out
4,272Employees

Margins

50.02%Gross
29.89%EBITDA
22.16%Operating
25.16%Pre-Tax
19.06%Net

Valuation

8.72P/E
0.94P/B
1.56EV/Sales
5.71EV/EBITDA
70.15P/FCF

Growth (CAGR)

11.81%Rev 3Yr
8.00%Rev 5Yr
21.49%Op Inc 3Yr
16.28%Op Inc 5Yr
21.19%Net Inc 3Yr
19.86%Net Inc 5Yr

Returns

7.74%ROA
11.35%ROE
10.32%ROIC

Financial Health

¥73,227,000,000Cash & Cash Equivalents
¥61,043,000,000Net Debt
40.67%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Tsumura & Co. (ticker: 4540) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 4,272 employees. Market cap is $282.6B.

The current price is 3,723 with a P/E ratio of 8.72x and P/B of 0.94x.

ROE is 11.35% and operating margin is 22.16%. Annual revenue is $181.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Tsumura & Co. (4540) Stock Forecast 2026 ¥3,723 — Price, Financials & Analyst Targets | Alpha Lenz